IKK:Biophysical basis of dynamic regulation
IKK:动态调节的生物物理基础
基本信息
- 批准号:7714251
- 负责人:
- 金额:$ 54.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2014-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdverse effectsAffectAnalytical CentrifugationArchitectureArthritisAtherosclerosisBindingBiochemicalBiochemical ReactionBiochemistryBiological AssayBiophysicsCatalytic DomainCell LineCell Surface ReceptorsCellsCharacteristicsChronicChronic DiseaseComplexComputer SimulationCoupledCrystallographyDevelopmentDiseaseDissociationDoseDrug Delivery SystemsEffectivenessEnzymesEquationEstimation TechniquesFamilyFeedbackGenesGeneticGoalsHalf-LifeHeat-Shock Proteins 90Human PathologyIkappaB kinaseImmuneImmune responseIn VitroInflammatoryInflammatory ResponseInterleukin-1InterventionKineticsLesionLibrariesMalignant Epithelial CellMalignant NeoplasmsMapsMass Spectrum AnalysisMeasuresMediatingMetastatic Squamous Cell CarcinomaMethodologyModelingMolecularMolecular ChaperonesMonitorMultienzyme ComplexesNF-kappa BNatural regenerationNeoplasm MetastasisNucleotidesOutcomePathogenesisPathologyPathway interactionsPeptide HydrolasesPharmaceutical PreparationsPharmacological TreatmentPhosphoric Monoester HydrolasesPhosphorylationPhosphorylation SitePhosphotransferasesPhysiologicalPhysiologyPlayProtein DephosphorylationProtein KinaseProtein Phosphatase 2A Regulatory Subunit PR53ProteinsReactionReceptor CellReceptor Down-RegulationRecyclingRegulationReportingRestRoleScaffolding ProteinSignal TransductionSignaling ProteinSpecificityStimulusStreamStructureStructure-Activity RelationshipTNF geneTestingTherapeuticTherapeutic InterventionTumor Necrosis Factor ReceptorWorkautocrinebasecancer cellcancer typecell typecrosslinkcytokinedesignhigh throughput screeningin vivoinhibitor/antagonistmathematical modelmutantnovelparacrinepublic health relevancereaction ratereceptorreconstitutionresearch studyresponseself assemblysimulationsmall moleculesrc-Family Kinasestext searchingtranscription factorubiquitin ligaseupstream kinase
项目摘要
DESCRIPTION (provided by applicant): IKK is the major signaling hub for inflammatory and innate immune responses. It is an enzyme complex that receives signals from a large number of cellular receptors regulates that activity of the NF-kB family of transcription factors. Misregulation of IKK is associated with many chronic diseases, such as chronic inflammatory pathologies (arthritis, atherosclerosis, etc) and many different types of cancer. Genetic evidence strongly supports IKK's critical and central role in many functions in physiology and pathology, but its potential as a drug target has not been realized. Mechanistic and biophysical studies have been lacking, and we have neither a kinetic understanding of IKK regulation nor structural information. However, what is clear is that IKK mediates signaling specificity by tight dynamic control that is stimulus-specific and induces the expression of specific sets of genes. Recent studies have reported on a tightly coupled activation and inactivation mechanism that can only be described by a multi-state activation-inactivation cycle that involves the function of several enzymes with different functions, such as ubiquitin ligases, kinases, phosphatases, and foldases. Through regulation of these activities, we hypothesize that the IKK cycle is driven in a stimulus- and cell type-specific manner, and that understanding the kinetic relationships will reveal opportunities for rationally targeted pharmacological intervention that discriminate between disease associated misregulation and stimulus-responsive regulation in healthy cells. In this proposal, we will construct a mathematical model of the IKK cycle to explore the dynamic regulation of IKK activity. We will then focus biochemical and biophysical studies on specific control mechanisms. In particular, we test the roles of IKK oligomerization, conformational changes, and upstream kinases in IKK activation and inhibition of IKK. Computational simulations will guide genetic and pharmacological manipulation of IKK dynamics. Finally, we will focus our study on how TNF and IL-1 produce differential dynamic control of IKK; how differential dose response and temporal control determine the efficacy of cytokine traps.
PUBLIC HEALTH RELEVANCE: The IkappaB kinase (IKK) complex is large protein kinase that specifically receives signals from cell surface receptors and transmits the signal to downstream effector transcription factor NF-kB. IKK must remain at a low activity state under resting state of the cell and transits into a high activity state upon receiving signals. Any alteration of this tight regulatory mode of IKK results to abnormal cellular outcomes including inflammatory diseases and cancer. The precise mechanism of how IKK-intrinsic and extrinsic cellular mechanisms control IKK activity is poorly understood. This proposal will integrate diverse methodologies that include mathematical modeling, biophysics, biochemistry and genetics to probe IKK regulation.
描述(由申请人提供):IKK 是炎症和先天免疫反应的主要信号传导中心。它是一种酶复合物,接收来自大量细胞受体的信号,调节 NF-kB 转录因子家族的活性。 IKK 的失调与许多慢性疾病有关,例如慢性炎症病理(关节炎、动脉粥样硬化等)和许多不同类型的癌症。遗传证据强烈支持 IKK 在生理学和病理学许多功能中的关键和核心作用,但其作为药物靶点的潜力尚未实现。一直缺乏机制和生物物理学研究,我们既没有对 IKK 调控的动力学理解,也没有结构信息。然而,显而易见的是,IKK 通过刺激特异性的严格动态控制来介导信号特异性,并诱导特定基因组的表达。最近的研究报告了紧密耦合的激活和失活机制,该机制只能通过多状态激活-失活循环来描述,该循环涉及多种具有不同功能的酶的功能,例如泛素连接酶、激酶、磷酸酶和折叠酶。通过对这些活动的调节,我们假设 IKK 循环以刺激和细胞类型特异性的方式驱动,并且了解动力学关系将揭示合理有针对性的药物干预的机会,从而区分疾病相关的失调和刺激响应调节在健康细胞中。在本提案中,我们将构建IKK循环的数学模型,以探索IKK活动的动态调控。然后我们将重点研究特定控制机制的生化和生物物理研究。特别是,我们测试了 IKK 寡聚化、构象变化和上游激酶在 IKK 激活和抑制中的作用。计算模拟将指导 IKK 动力学的遗传和药理学操作。最后,我们将重点研究TNF和IL-1如何对IKK产生差异动态控制;不同的剂量反应和时间控制如何决定细胞因子陷阱的功效。
公共健康相关性:IkappaB 激酶 (IKK) 复合物是一种大型蛋白激酶,专门接收来自细胞表面受体的信号并将信号传输至下游效应转录因子 NF-kB。 IKK在细胞静息状态下必须保持在低活性状态,并在接收到信号后转变为高活性状态。 IKK 这种严格调节模式的任何改变都会导致异常的细胞结果,包括炎症性疾病和癌症。 IKK 内在和外在细胞机制如何控制 IKK 活性的精确机制尚不清楚。该提案将整合数学模型、生物物理学、生物化学和遗传学等多种方法来探索 IKK 调控。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GOURISANKAR GHOSH其他文献
GOURISANKAR GHOSH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GOURISANKAR GHOSH', 18)}}的其他基金
Suppressing Inflammation by Blocking IKK Oligomer
通过阻断 IKK 寡聚物抑制炎症
- 批准号:
10446098 - 财政年份:2022
- 资助金额:
$ 54.46万 - 项目类别:
Suppressing Inflammation by Blocking IKK Oligomer
通过阻断 IKK 寡聚物抑制炎症
- 批准号:
10573218 - 财政年份:2022
- 资助金额:
$ 54.46万 - 项目类别:
Investigation of Gene Regulation by NF-kappaB Transcription factors
NF-kappaB 转录因子基因调控的研究
- 批准号:
8067860 - 财政年份:2009
- 资助金额:
$ 54.46万 - 项目类别:
Cofactor-Mediated DNA Binding by the NF-kappaB Dimers
NF-kappaB 二聚体辅助因子介导的 DNA 结合
- 批准号:
10593119 - 财政年份:2009
- 资助金额:
$ 54.46万 - 项目类别:
Investigation of Gene Regulation by NF-kappaB Transcription factors
NF-kappaB 转录因子基因调控的研究
- 批准号:
7883453 - 财政年份:2009
- 资助金额:
$ 54.46万 - 项目类别:
相似国自然基金
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
D.formicigenerans菌通过调控FoxP3-Treg影响PD-1抑制剂所致免疫相关不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Multifunctional Nanoparticle Platform to Prevent Alcohol-Associated HCC Development
多功能纳米颗粒平台可预防酒精相关的 HCC 发展
- 批准号:
10736984 - 财政年份:2023
- 资助金额:
$ 54.46万 - 项目类别:
Impact of Structural Racism on Racial Disparities in Cognitive Impairment
结构性种族主义对认知障碍种族差异的影响
- 批准号:
10572864 - 财政年份:2023
- 资助金额:
$ 54.46万 - 项目类别:
Neural and Renal Contributions to Hypertension with Androgen Deprivation Therapy
雄激素剥夺疗法对高血压的神经和肾脏影响
- 批准号:
10662133 - 财政年份:2023
- 资助金额:
$ 54.46万 - 项目类别:
Risk factors for chronic obstructive pulmonary disease exacerbations, quality of care, and outcomes in people with HIV
HIV 感染者慢性阻塞性肺病恶化的危险因素、护理质量和结果
- 批准号:
10700228 - 财政年份:2023
- 资助金额:
$ 54.46万 - 项目类别:
ELEVATE Center: Reduction of Maternal Morbidity from Substance Use Disorder in Utah
ELEVATE 中心:降低犹他州药物使用障碍导致的孕产妇发病率
- 批准号:
10748243 - 财政年份:2023
- 资助金额:
$ 54.46万 - 项目类别: